Cefdinir showed nearly double the treatment failure rate compared to cephalexin in outpatient uUTI management. Cefdinir's lower bioavailability and urinary excretion contribute to its reduced efficacy ...
To earn CME related to this news article, click here. March 18, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn against use of hydrocodone bitartrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback